Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) Interest Expenses (2016 - 2026)

AC Immune has reported Interest Expenses over the past 11 years, most recently at -$83005.3 for Q1 2026.

  • Quarterly Interest Expenses fell 38.2% to -$83005.3 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$253454.0 through Mar 2026, down 292.93% year-over-year, with the annual reading at -$238973.4 for FY2025, 259.81% down from the prior year.
  • Interest Expenses was -$83005.3 for Q1 2026 at AC Immune, down from -$52549.1 in the prior quarter.
  • Over five years, Interest Expenses peaked at $267116.1 in Q4 2024 and troughed at -$730767.4 in Q4 2022.
  • The 5-year median for Interest Expenses is -$57505.0 (2025), against an average of -$93802.4.
  • Year-over-year, Interest Expenses tumbled 7438.14% in 2022 and then soared 172.46% in 2024.
  • A 5-year view of Interest Expenses shows it stood at -$730767.4 in 2022, then surged by 49.55% to -$368644.9 in 2023, then soared by 172.46% to $267116.1 in 2024, then tumbled by 119.67% to -$52549.1 in 2025, then plummeted by 57.96% to -$83005.3 in 2026.
  • Per Business Quant, the three most recent readings for ACIU's Interest Expenses are -$83005.3 (Q1 2026), -$52549.1 (Q4 2025), and -$57505.0 (Q3 2025).